Tapeab.io
Home/Ticker/CRL
File: CRLCLIPPED · 2026-11-04

CRLCharles River Laboratories

Mkt cap $9B
Sector benchmark XLV
326.29
−7.3%
±9.9%into Nov 20282.12–343.92±9.9%monthly282.12–343.92Pullback · —Knife · —Momentum · Held 3mo · #15DP short-vol · 45% ▾ easing
Price · 6 months · daily
6m high376.10
6m low149.93
Vol vs 20d avg1.4×
Off 52-wk high-13.2%

CRL dark pool FINRA · T+1

SVR 50%SHORT-VOL RATIO · 40 SESSIONS
Short-vol ratio45% · easing
Off-exchange share39%
vs own 1-yr (z)-0.6

CRL sector RS vs XLV

+6.6%vs XLV · 63 sessions
CRL vs XLV · 3m+6.6%
CRL vs XLV · 6m+37.7%
ratio of closes, rebased — a relative read, not a peer percentile

CRL gamma profile CBOE delayed

Call wall350.00
Zero-gamma315.00
Put wall330.00
Spot vs zero-γ3.6% above
Dealer posturelong gamma · dampens moves
nearest expiry 2026-11-20 · as of 2026-11-05 · heuristics · full profile →

CRL fundamentals SEC filings · TTM

P/Etrailing—
P/Elast FY—
P/E3-yr median26x
EPStrailing−$4.97
EPSFY to Dec 2025−$2.91
Revenue$4.0B · −0.7%
Income−$238.5M
Margin2.3%
10-Q · filed 5 Aug 2026 · Fundamentals as of 2026-11-04 · latest session 2026-11-05

CRL earnings reactions two-session move

8.9%typical move
Nov 2023 → Aug 2026
Revenue and profit by quarter
PriceRevenueProfitLoss
$1.0B
FY23 Q4
FY24 Q2
FY24 Q4
FY25 Q2
FY25 Q4
FY26 Q2
P/E history
PriceP/E3-yr median

CRL dividends per share · Yahoo · SEC

No dividend.

CRL gamma history nightly

0NET GEX $M · ALL EXPIRIES
25 Sep → 5 Nov · full history →

CRL session over session 4 Nov → 5 Nov

Expected move · monthly 20 Nov9.87%+0.63 pp
Call and put wallheld their strikes
full listed chain, a separate capture from the gamma panel · CBOE delayed
Auto-note //Holding above zero-gamma (315.00) — dealer hedging dampens moves above it. The 350.00 call wall is the nearest-expiry ceiling heuristic; 330.00 is the floor. Options price ±9.9% into Nov 20. Dark-pool short volume at 45% and easing vs its 20-day.
Composed from the nightly pipelines — every panel degrades independently when its dataset is missing. Heuristics labeled as heuristics; not investment advice.